Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol Hydrochloride Orally Disintegrating Tablets in Male Subjects with Premature Ejaculation
2009-011411-21Phase 3Terminated
- Sponsor
- Biovail Laboratories International
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tramadol in premature ejaculation (PE) (3 arms), sponsored by Biovail Laboratories International. Primary endpoint: Co-primary efficacy endpoints. Started Jun 2009; status: terminated.
02
Drugs
tramadol
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on 2009-011411-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011411-21.